| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |